Page last updated: 2024-08-18

4-butyrolactone and Weight Loss

4-butyrolactone has been researched along with Weight Loss in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ariza, X; Asins, G; Bentebibel, A; Cordente, AG; García, J; Gómez-Puertas, P; Gurunathan, C; Hegardt, FG; Herrero, L; López-Viñas, E; Mera, P; Sebastián, D; Serra, D; Vázquez, I1
Blancafort, A; Cufí, S; Haro, D; Marrero, PF; Oliveras, G; Puig, T; Relat, J1
Cone, RD; Liu, H; Smart, JL; Takahashi, KA1
Kim, EK; Kleman, AM; Landree, LE; Ronnett, GV; Tu, Y1
Bouchard, C1
Kuhajda, FP; Landree, LE; Ronnett, GV; Thupari, JN1

Reviews

2 review(s) available for 4-butyrolactone and Weight Loss

ArticleYear
Fatty acid metabolism, the central nervous system, and feeding.
    Obesity (Silver Spring, Md.), 2006, Volume: 14 Suppl 5

    Topics: 4-Butyrolactone; Central Nervous System; Eating; Energy Intake; Energy Metabolism; Fatty Acid Synthases; Fatty Acids; Gene Expression; Humans; Obesity; Oxidation-Reduction; Weight Loss

2006
Inhibition of food intake by inhibitors of fatty acid synthase.
    The New England journal of medicine, 2000, Dec-21, Volume: 343, Issue:25

    Topics: 4-Butyrolactone; Acetyl-CoA Carboxylase; Animals; Eating; Enzyme Inhibitors; Fatty Acid Synthases; Humans; Mice; Neuropeptide Y; Obesity; Triglycerides; Weight Loss

2000

Other Studies

4 other study(ies) available for 4-butyrolactone and Weight Loss

ArticleYear
C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.
    Biochemical pharmacology, 2009, Mar-15, Volume: 77, Issue:6

    Topics: 4-Butyrolactone; Acyl Coenzyme A; Animals; Binding Sites; Body Weight; Carnitine O-Palmitoyltransferase; Eating; Female; Humans; Hypothalamus; Mice; Protein Structure, Secondary; Rats; Rats, Sprague-Dawley; Weight Loss

2009
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.
    BMC cancer, 2012, Jul-06, Volume: 12

    Topics: 4-Butyrolactone; Adenocarcinoma; Adenocarcinoma of Lung; Analysis of Variance; Animals; Apoptosis; Carnitine O-Palmitoyltransferase; Catechin; Cell Line, Tumor; Fatty Acid Synthases; Fatty Acids; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Random Allocation; Signal Transduction; Weight Loss; Xenograft Model Antitumor Assays

2012
The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
    Endocrinology, 2004, Volume: 145, Issue:1

    Topics: 4-Butyrolactone; Action Potentials; Animals; Arcuate Nucleus of Hypothalamus; Eating; Fatty Acid Synthases; Feces; Female; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Pro-Opiomelanocortin; Purkinje Cells; Weight Loss

2004
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Jul-09, Volume: 99, Issue:14

    Topics: 3T3 Cells; 4-Butyrolactone; Adenosine Triphosphate; Adipocytes; Animals; Carnitine O-Palmitoyltransferase; Diet; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acid Synthases; Fatty Acids; Humans; Male; Malonyl Coenzyme A; Mice; Mice, Inbred C57BL; Obesity; Oxidation-Reduction; Tumor Cells, Cultured; Weight Loss

2002